Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
AMAL Stock Summary
Top 10 Correlated ETFs
AMAL
In the News
Should Value Investors Buy Amalgamated Financial (AMAL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Amalgamated Financial: Earnings Outlook Remains Positive Thanks To Loans And Margin
Planned changes in the balance sheet will likely boost Amalgamated Financial's net interest margin this year. Local job markets give hope that loan growth can remain at a decent level. The December 2024 target price suggests a moderate upside. Further, AMAL is offering a low dividend yield.
Are Investors Undervaluing Amalgamated Financial (AMAL) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Amalgamated Financial (AMAL) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Amalgamated Financial (AMAL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Amalgamated Financial (AMAL) Q4 Earnings Lag Estimates
Amalgamated Financial (AMAL) came out with quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.83 per share a year ago.
Amalgamated Financial Corp. Announces Fourth Quarter and Full Year 2023 Earnings Conference Call
NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Amalgamated Financial Corp. (“Amalgamated” or the “Company”) (Nasdaq: AMAL) today announced that its fourth quarter and full year 2023 financial results will be released before market open on Thursday, January 25, 2024. The Company will host a conference call at 11:00 a.m. Eastern Time on the same day to discuss the financial results.
Should Value Investors Buy Amalgamated Financial (AMAL) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here Are 5 Top-Ranked Plays With Relative Price Strength
CVLT, MNTX, AMAL, GIC and CVEO are five stocks with explosive relative price strength.
Amalgamated Financial Corp. (AMAL) Q3 2023 Earnings Call Transcript
Amalgamated Financial Corp. (NASDAQ:AMAL ) Q3 2023 Earnings Conference Call October 26, 2023 11:00 AM ET Company Participants Jason Darby - Chief Financial Officer Priscilla Sims Brown - President & Chief Executive Officer Conference Call Participants Chris O'Connell - KBW Operator Good morning, ladies and gentlemen, and welcome to the Amalgamated Financial Corporation Third Quarter 2023 Earnings Conference Call. During today's presentation, all parties will be on a listen only mode.
Compared to Estimates, Amalgamated Financial (AMAL) Q3 Earnings: A Look at Key Metrics
The headline numbers for Amalgamated Financial (AMAL) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
AMAL Financial details
AMAL Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 6.17 | 6.85 | 6.51 | 8.65 | 12.52 | |
Net income per share | 1.49 | 1.48 | 1.7 | 2.64 | 2.88 | |
Operating cash flow per share | 2.63 | 2.11 | 2.27 | 4.78 | 3.73 | |
Free cash flow per share | 2.61 | 2.06 | 2.19 | 4.73 | 3.68 | |
Cash per share | 42.46 | 50.71 | 78.57 | 60.87 | 51.5 | |
Book value per share | 15.45 | 17.21 | 18.12 | 16.51 | 19.15 | |
Tangible book value per share | 162.87 | 189.74 | 222.76 | 15.99 | 18.35 | |
Share holders equity per share | 15.45 | 17.21 | 18.12 | 16.51 | 19.15 | |
Interest debt per share | 7.64 | 2.36 | 4.83 | 23.64 | 10.86 | |
Market cap | 617.21M | 427.77M | 521.61M | 710.05M | 823.15M | |
Enterprise value | 632.07M | 442.17M | 324.29M | 1.34B | 1.07B | |
P/E ratio | 13.08 | 9.26 | 9.85 | 8.71 | 9.36 | |
Price to sales ratio | 3.15 | 2.01 | 2.58 | 2.66 | 2.15 | |
POCF ratio | 7.4 | 6.5 | 7.39 | 4.82 | 7.22 | |
PFCF ratio | 7.46 | 6.67 | 7.65 | 4.87 | 7.32 | |
P/B Ratio | 1.26 | 0.8 | 0.93 | 1.4 | 1.41 | |
PTB ratio | 1.26 | 0.8 | 0.93 | 1.4 | 1.41 | |
EV to sales | 3.23 | 2.07 | 1.6 | 5.05 | 2.79 | |
Enterprise value over EBITDA | 9.01 | 6.36 | 4.51 | 10.24 | 1.2K | |
EV to operating cash flow | 7.57 | 6.72 | 4.6 | 9.13 | 9.37 | |
EV to free cash flow | 7.64 | 6.89 | 4.76 | 9.23 | 9.49 | |
Earnings yield | 0.08 | 0.11 | 0.1 | 0.11 | 0.11 | |
Free cash flow yield | 0.13 | 0.15 | 0.13 | 0.21 | 0.14 | |
Debt to equity | 0.46 | 0.12 | 0.26 | 1.39 | 0.54 | |
Debt to assets | 0.04 | 0.01 | 0.02 | 0.09 | 0.04 | |
Net debt to EBITDA | 0.21 | 0.21 | -2.74 | 4.83 | 275.9 | |
Current ratio | 0.39 | 0.34 | 0.43 | 0.32 | 0.03 | |
Interest coverage | 3.32 | 5.91 | 11.37 | 6.8 | -0.23 | |
Income quality | 1.77 | 1.42 | 1.33 | 1.81 | 1.3 | |
Dividend Yield | 0.01 | 0.02 | 0.02 | 0.02 | 0.01 | |
Payout ratio | 0.18 | 0.22 | 0.19 | 0.14 | 0.14 | |
Sales general and administrative to revenue | 0.43 | 0.39 | 0.44 | 0.29 | 0.23 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -0.01 | -0.02 | -0.03 | -0.01 | -0.01 | |
Capex to revenue | 0 | -0.01 | -0.01 | -0.01 | 0 | |
Capex to depreciation | -0.13 | -0.21 | -0.49 | -0.36 | -0.33 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham number | 22.74 | 23.97 | 26.34 | 31.34 | 35.23 | |
ROIC | 0.06 | 0.07 | 0.07 | 0.08 | 0 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Graham Net | 36.33 | 45.71 | 65.19 | -178.42 | -262.26 | |
Working capital | -2.12B | -3.13B | -3.31B | -4.08B | -6.05B | |
Tangible asset value | 5.17B | 5.91B | 6.93B | 492.91M | 560.64M | |
Net current asset value | 1.23B | 1.55B | 2.34B | -5.42B | -7.2B | |
Invested capital | 0.46 | 0.12 | 0.26 | 1.39 | 0.54 | |
Average receivables | 16.74M | 21.53M | 26.4M | 35.13M | 48.46M | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | -71.21M | -191.52M | -424.87M | -375.98M | -2.3B | |
Days sales outstanding | 35.58 | 41.04 | 51.94 | 56.76 | 52.95 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 10.26 | 8.89 | 7.03 | 6.43 | 6.89 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.1 | 0.09 | 0.09 | 0.16 | 0.15 | |
Capex per share | -0.02 | -0.05 | -0.08 | -0.05 | -0.05 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.38 | 2.36 | 2.3 | 2.99 | 3.34 | |
Net income per share | 0.81 | 0.69 | 0.71 | 0.73 | 0.75 | |
Operating cash flow per share | 1.71 | 1.14 | 0.89 | 1.31 | 0.49 | |
Free cash flow per share | 1.7 | 1.13 | 0.87 | 1.29 | 0.48 | |
Cash per share | 61.15 | 57.64 | 53.76 | 53.53 | 51.73 | |
Book value per share | 16.58 | 16.9 | 17.26 | 17.92 | 19.24 | |
Tangible book value per share | 16.07 | 246.48 | 242.91 | 247.9 | 18.43 | |
Share holders equity per share | 16.58 | 16.9 | 17.26 | 17.92 | 19.24 | |
Interest debt per share | 23.5 | 13.62 | 19.35 | 19.54 | 10.51 | |
Market cap | 706.87M | 543.19M | 492.66M | 524.88M | 819.46M | |
Enterprise value | 1.34B | 664.36M | 766.51M | 722.71M | 1.06B | |
P/E ratio | 7.14 | 6.36 | 5.69 | 5.88 | 9.03 | |
Price to sales ratio | 9.68 | 7.51 | 7 | 5.75 | 8.06 | |
POCF ratio | 13.48 | 15.59 | 18.07 | 13.19 | 54.84 | |
PFCF ratio | 13.52 | 15.7 | 18.47 | 13.32 | 55.8 | |
P/B Ratio | 1.39 | 1.05 | 0.93 | 0.96 | 1.4 | |
PTB ratio | 1.39 | 1.05 | 0.93 | 0.96 | 1.4 | |
EV to sales | 18.38 | 9.18 | 10.89 | 7.92 | 10.46 | |
Enterprise value over EBITDA | 30.57 | 13.94 | 26.02 | 23.2 | 4.79K | |
EV to operating cash flow | 25.58 | 19.06 | 28.12 | 18.16 | 71.23 | |
EV to free cash flow | 25.67 | 19.21 | 28.73 | 18.33 | 72.49 | |
Earnings yield | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | |
Free cash flow yield | 0.07 | 0.06 | 0.05 | 0.08 | 0.02 | |
Debt to equity | 1.39 | 0.77 | 1.08 | 1.04 | 0.54 | |
Debt to assets | 0.09 | 0.05 | 0.07 | 0.07 | 0.04 | |
Net debt to EBITDA | 14.47 | 2.54 | 9.3 | 6.35 | 1.1K | |
Current ratio | 0.32 | 0.63 | 0.65 | 0.68 | 0.03 | |
Interest coverage | 3.82 | 2.64 | 1.28 | 1.13 | -0.26 | |
Income quality | 2.12 | 1.63 | 1.26 | 1.78 | 0.66 | |
Dividend Yield | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Payout ratio | 0.13 | 0.14 | 0.15 | 0.14 | 0.13 | |
Sales general and administrative to revenue | 0.09 | 0.32 | 0.32 | 0.02 | 0.22 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.01 | -0.02 | -0.01 | -0.02 | |
Capex to revenue | 0 | 0 | -0.01 | 0 | 0 | |
Capex to depreciation | -0.16 | -0.24 | -0.52 | -0.34 | -0.23 | |
Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
Graham number | 17.35 | 16.26 | 16.57 | 17.18 | 17.97 | |
ROIC | 0.03 | 0.04 | 0.02 | 0.02 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | -179.22 | 115.38 | 110.96 | 111.67 | -190.93 | |
Working capital | -4.08B | -2.5B | -2.28B | -2.09B | -6.05B | |
Tangible asset value | 492.91M | 7.57B | 7.44B | 7.56B | 560.64M | |
Net current asset value | -5.42B | 3.99B | 3.96B | 4.08B | -7.2B | |
Invested capital | 1.39 | 0.77 | 1.08 | 1.04 | 0.54 | |
Average receivables | 38.1M | 41.14M | 42.47M | 45.92M | 51.61M | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | -218.33M | 1.92B | 4.05B | 4.13B | 2.05B | |
Days sales outstanding | 51.1 | 50.82 | 56.4 | 47.1 | 49.09 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 1.76 | 1.77 | 1.6 | 1.91 | 1.83 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | |
Capex per share | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
AMAL Frequently Asked Questions
What is Amalgamated Financial Corp. stock symbol ?
Amalgamated Financial Corp. is a US stock , located in New york of Ny and trading under the symbol AMAL
Is Amalgamated Financial Corp. buy or a sell ?
1 stock analysts have 1 predictions with a medium analyst target price of $28. The lowest prediction is $28 and the highest is $28
What is AMAL stock prediction ?
What is Amalgamated Financial Corp. stock quote today ?
Amalgamated Financial Corp. stock price is $23.94 today.
Is Amalgamated Financial Corp. stock public?
Yes, Amalgamated Financial Corp. is a publicly traded company.